TY - CHAP M1 - Book, Section TI - Endocrine and Metabolic Complications of Cancer Therapy A1 - Ozsari, Levent A1 - Busaidy, Naifa L. A1 - Habra, Mouhammed A. A2 - Kantarjian, Hagop M. A2 - Wolff, Robert A. PY - 2016 T2 - The MD Anderson Manual of Medical Oncology, 3e AB - In the past two decades, cancer research has rapidly advanced, spurred by the development of high-throughput technology and the maturation of genomic and proteomic research methods. These advances have resulted in treatments that have substantial effects on the outcomes of certain cancers. The continuous development of new antineoplastic agents adds increasing challenges for practicing physicians. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - hemonc.mhmedical.com/content.aspx?aid=1126746261 ER -